L. Emens

Oncology · 2015–2019

A researcher in the Science corpus: 6 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom L. Emens trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll
  2. D. DeNardo
  3. M. Smyth
  4. S. Demaria
  5. S. Topalian
  6. François Ghiringhelli
  7. M. Postow
  8. Lisa M. Coussens

Who trusts L. Emens overall

  1. Yun R Li

Papers from L. Emens's perspective

Ordered by how strongly the researchers L. Emens trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice (Science)
  2. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (Nature Medicine)
  3. Immunogenic death of colon cancer cells treated with oxaliplatin (Oncogene)
  4. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  5. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. (New England Journal of Medicine)
  6. Immune checkpoint blockade: a common denominator approach to cancer therapy (Cancer Cell)
  7. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. (Advances in Immunology)
  8. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy (Nature Reviews. Cancer)
  9. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression (Breast Cancer Research)
  10. Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity (Clinical Cancer Research)

Their papers